Beneficial dose conversion after switching from higher...

Beneficial dose conversion after switching from higher doses of shorter-acting erythropoiesis-stimulating agents to C.E.R.A in CKD patients in clinical practice: MINERVA Study

Cases, Aleix, Portolés, José, Calls, Jordi, Martinez-Castelao, Alberto, Munar, María Antonia, Segarra, Alfonso
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
46
Language:
english
Journal:
International Urology and Nephrology
DOI:
10.1007/s11255-014-0800-4
Date:
October, 2014
File:
PDF, 390 KB
english, 2014
Conversion to is in progress
Conversion to is failed